RHAMM (CD168) is overexpressed at the protein level and may constitute an immunogenic antigen in advanced prostate cancer disease.

导出 OA

翻译打印收藏纠错

作者： Kilian M,Gust ^[1] ; Matthias D,Hofer ; Sven R,Perner ; Robert,Kim ; Arul M,Chinnaiyan ; Sooryanarayana,Varambally ; Peter,Moller ; Ludwig,Rinnab ; Mark A,Rubin ; Jochen,Greiner ; Michael,Schmitt ; Rainer,Kuefer ; Mark,Ringhoffer

作者单位： Department of Urology, University of Ulm, Ulm, Germany. ^[1]

主题词抗原, 肿瘤(Antigens, Neoplasm);细胞凋亡(Apoptosis);细胞增殖(Cell Proliferation);数据库, 事实型(Databases, Factual);细胞外基质蛋白质类(Extracellular Matrix Proteins);基因表达谱(Gene Expression Profiling);人类(Humans);免疫酶技术(Immunoenzyme Techniques);淋巴转移(Lymphatic Metastasis);男(雄)性(Male);寡核苷酸序列分析(Oligonucleotide Array Sequence Analysis);前列腺(Prostate);前列腺增生(Prostatic Hyperplasia);前列腺肿瘤(Prostatic Neoplasms);存活率(Survival Rate);组织阵列分析(Tissue Array Analysis);肿瘤细胞, 培养的(Tumor Cells, Cultured)

DOI 10.1593/neo.09694

PMID 19724689

发布时间 2022-03-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览26

Neoplasia (New York, N.Y.)

2009年11卷9期

956-63页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

RHAMM (CD168) is overexpressed at the protein level and may constitute an immunogenic antigen in advanced prostate cancer disease.

Neoplasia (New York, N.Y.)

相似文献

Neoplasia (New York, N.Y.)

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

RHAMM (CD168) is overexpressed at the protein level and may constitute an immunogenic antigen in advanced prostate cancer disease.

Neoplasia (New York, N.Y.)

相似文献

Neoplasia (New York, N.Y.)

相关期刊

检索历史清除